Table 2 Limb and lesion characteristics.
From: Two year comparative outcomes of drug coated balloons in long versus short femoropopliteal lesions
Limb and lesion characteristics | Lesion length > 15 cm N = 115a | Lesion length ≤ 15 cm N = 141a | p - value |
|---|---|---|---|
Bilateral disease b, % (n/N) | 86.1 (99/115) | 77.3 (109/141) | 0.073 |
ABI, per target limb, mm Hg, (mean ± SD) | 0.29 ± 0.27 | 0.42 ± 0.29 | 0.002 |
Occlusion, % (n/N) | 90.4 (104/115) | 53.9 (76/141) | < 0.001 |
Lesion type, % (n/N) | 0.038 | ||
De novo | 68.7 (79/115) | 82.3 (116/141) | 0.011 |
Restenotic (nonstented) | 8.7 (10/115) | 5.7 (8/141) | 0.347 |
In-stent restenosis | 22.6 (26/115) | 12.1 (17/141) | 0.025 |
Calcification, % (n/N) | 0.550 | ||
None | 44.3 (51/115) | 51.1 (72/141) | 0.285 |
Mild | 43.5 (50/115) | 39.0 (55/141) | 0.469 |
Severe | 12.2 (14/115) | 9.9 (14/141) | 0.567 |
Below-the-knee outflow, % (n/N) | 0.271 | ||
None | 6.1 (7/115) | 9.9 (14/141) | 0.265 |
1 vessel | 34.8 (40/115) | 29.8 (42/141) | 0.394 |
2 vessels | 41.7 (48/115) | 35.5 (50/141) | 0.304 |
3 vessels | 17.4 (20/115) | 24.8 (35/141) | 0.150 |
Rutherford Clinical Category, % (n/N) | 0.110 | ||
3 | 45.9 (51/111) | 55.4 (77/139) | 0.087 |
4 | 26.1 (29/111) | 28.8 (40/139) | 0.374 |
5 | 25.2 (28/111) | 15.1 (21/139) | 0.033 |
6 | 2.7 (3/111) | 0.7 (1/139) | 0.232 |
TASC II, % (n/N) | < 0.001 | ||
A | 0 | 36.9 (52/141) | < 0.001 |
B | 0 | 61.7 (87/141) | < 0.001 |
C | 45.2 (52/115) | 0.7 (1/141) | < 0.001 |
D | 54.8 (68/115) | 0.7 (1/141) | < 0.001 |
Atherectomy, % (n/N) | 5.2 (6/115) | 4.3 (6/141) | 0.717 |
Bailout stenting, % (n/N) | 15.7 (18/115) | 9.9 (14/141) | 0.168 |
Dissection | 8.7 (10/115) | 7.1 (10/141) | 0.634 |
Residual stenosis | 5.2 (6/115) | 2.1 (3/141) | 0.306 |
Dissection + Residual stenosis | 1.7 (2/115) | 0.7 (1/141) | 0.589 |